Skip to content

Sodium Bicarbonate: Research, Forms and Safety

Published · Automatically source-checked · By Tigoo redaktionSupplements

Short answer

Sodium bicarbonate, also called baking soda, is the compound NaHCO₃. Sports research has studied it in exercise settings, but the findings vary by outcome and do not establish a universal result.

Quick facts

  • Its chemical formula is NaHCO₃.
  • Baking soda is an everyday name for sodium bicarbonate.
  • A team-sport meta-analysis included 20 studies and 241 athletes.
  • Gastrointestinal symptoms were reported in studies of supplementation protocols.
Sodium Bicarbonate: Research, Forms and Safety

What sodium bicarbonate is

Sodium bicarbonate is a chemical compound with the formula NaHCO3. The formula identifies the elements in the compound: sodium (Na), hydrogen (H), carbon (C) and oxygen (O). “Sodium bicarbonate” is its chemical name; “baking soda” is the familiar everyday name for the same compound. A 2026 review of sodium bicarbonate in sports research uses the abbreviation NaHCO3 for sodium bicarbonate.

The two names are useful in different contexts. Baking soda is the common household term, while sodium bicarbonate or NaHCO3 is more precise in scientific and technical writing. In sports research, authors commonly shorten the name to “SB” after introducing sodium bicarbonate. These are different ways of referring to the same compound, not different substances. The review describes sodium bicarbonate as an extracellular buffering agent and discusses its use in exercise research.

“Buffering agent” describes the role examined in that research: sodium bicarbonate is studied in relation to buffering outside cells. The review covers questions about proposed mechanisms, ways of taking it, changes in blood bicarbonate, and exercise performance. This is a research context, not a definition of baking soda as a medicine or a statement about health effects. The review outlines these topics while also noting that questions remain about effectiveness and potential side effects in the settings it discusses.

In short, NaHCO3 is the chemical formula, sodium bicarbonate is the chemical name, and baking soda is the everyday name. In sports research, sodium bicarbonate is described as an extracellular buffering agent; that description identifies the topic being studied, rather than making a claim about what a supplement does for an individual. The 2026 review provides this sports-research context.

How sodium bicarbonate is studied in sport

Sports research examines sodium bicarbonate as an extracellular buffering agent. A 2026 review notes that sodium bicarbonate has been investigated in hundreds of exercise studies, while questions remain about its effects, possible side effects and the best ways to use it in research protocols. The review of common questions and misconceptions

Studies vary in the exercise task they test. Researchers may examine short-duration or longer-duration exercise, repeated efforts, high-intensity intervals or other performance measures. They also compare different ways of ingesting sodium bicarbonate and different timings relative to exercise, alongside measurements such as blood bicarbonate and pH. These design differences matter: a result for one type of exercise or one outcome cannot automatically be applied to another. The 2026 review specifically discusses ingestion methods, changes in blood bicarbonate and timing, including when levels peak. Its overview of research questions

A recent systematic review and meta-analysis focused on high-intensity intermittent exercise in team-sport athletes. It included 20 studies and 241 athletes, contributing 53 performance estimates. The pooled result showed a small beneficial effect on high-intensity intermittent exercise performance (Hedges’ g = 0.23; 95% confidence interval 0.07 to 0.39). However, the prediction interval ranged from -0.22 to 0.68, so results across settings may vary. The authors found no clear effects for repeated-sprint performance, mean power, intermittent endurance or work capacity. They also did not identify significant moderators among the factors they tested, including dose, formulation, ingestion frequency, exercise phase and work-to-rest ratio. The team-sport meta-analysis

These findings are best read as evidence about specific study outcomes, not a guarantee of an individual response. In particular, a small pooled effect for one broad category does not establish a clear benefit for every repeated-sprint test or team-sport activity. Differences in exercise protocols, ingestion approaches and timing remain important when interpreting the research. The team-sport review and the broader review

What the evidence can and cannot show

The sports evidence is broader than one event or one performance measure, but it does not point to a uniform result. A systematic review and meta-analysis focused on high-intensity intermittent exercise in team-sport athletes included 20 studies and 241 athletes. Across 53 performance effect sizes, it found a small pooled effect in favour of sodium bicarbonate (Hedges’ g = 0.23; 95% confidence interval 0.07 to 0.39). However, the prediction interval ranged from -0.22 to 0.68, spanning no effect. That interval signals that results in a new study could differ from the overall average, including showing no benefit. The team-sport meta-analysis

The pooled result also needs to be read alongside the review’s outcome-specific findings: it identified no clear effects for repeated-sprint performance, mean power, intermittent endurance or work capacity. Its analyses did not identify significant moderating effects of sex, dose, ingestion frequency, formulation, exercise phase or work-to-rest ratio. These analyses do not establish that the factors never matter; they mean that this evidence did not clearly show that they explained differences in results. The review’s results

A study-level average is not a promise about what will happen for any one athlete. The pooled estimate combines results across studies, while individual responses may vary; the prediction interval’s inclusion of no effect underlines that uncertainty. A small average effect should therefore not be translated into a guarantee of a noticeable improvement for an individual or every team-sport situation. The meta-analysis and its prediction interval

  • What this evidence can show: in the studies included, the average result across a range of high-intensity intermittent team-sport performance measures was small and favoured sodium bicarbonate. The team-sport meta-analysis
  • The prediction interval spanning no effect is an important limit. The review’s performance findings
  • What it is not: evidence of a general health benefit or an authorised health claim. These findings concern exercise-performance outcomes in the studied sports context only. The study’s stated scope

Overall, the available team-sport findings suggest a small average performance effect, alongside substantial uncertainty about how consistently that result applies. They do not support treating a study-level estimate as a prediction for a particular person. The systematic review and meta-analysis

Forms, timing and gastrointestinal tolerability

Sodium bicarbonate has been studied in different delivery formats and dosing schedules, but the available evidence does not establish one approach as best tolerated. A 2026 review of common questions about sodium bicarbonate discusses how the method of ingestion may affect blood bicarbonate changes and exercise performance, as well as when it may be taken before exercise. Its scope reflects ongoing questions rather than a single settled timing rule. The review

Gastrointestinal symptoms are an important part of this discussion. A systematic review summarised 101 investigations of sodium bicarbonate protocols, including studies of acute single dosing, spread dosing, chronic dosing and delivery forms. It reports that common acute doses of 0.2–0.4 g/kg may be associated with symptoms ranging from mild to severe. Symptoms may increase when a larger amount is taken as one dose. The systematic review

Delivery methods studied

Researchers have examined several ways of taking sodium bicarbonate with the aim of reducing gastrointestinal symptoms:

  • Spread dosing: dividing intake across a period of hours rather than taking it all at once.
  • Enteric-coated forms: capsules or tablets designed to alter where the contents are released.
  • Mini-tablets in carbohydrate hydrogel: a delivery approach included in the reviewed literature.

These are strategies investigated in studies, not proven instructions for use. Direct comparisons between them are absent from the evidence summarised in the review, so their effectiveness for reducing symptoms cannot be ranked. The review also notes that multi-day dosing may lessen symptoms, but symptom recording across supplementation periods is often incomplete. Review of gastrointestinal symptoms

Timing is not a one-size-fits-all answer

The timing question includes whether sodium bicarbonate is taken before exercise, and when blood bicarbonate reaches its peak. These are explicitly identified as questions in the 2026 review, but the information available here does not provide a universal timing recommendation. It is therefore more accurate to distinguish the timing questions researchers have studied from practical directions that the evidence does not establish. Review of sodium bicarbonate research questions

Overall, dose, schedule and form are all relevant when interpreting tolerability findings, but current comparisons do not identify a clearly superior strategy. The systematic review also reports that some included studies did not statistically test differences in gastrointestinal symptoms, adding to the limits on firm conclusions. Systematic review of gastrointestinal symptoms

Sodium bicarbonate and blood pH

In research on sodium bicarbonate and exercise, blood bicarbonate concentration and blood pH are measurements used to describe changes in the body. They are study outcomes—not consumer health claims, and not evidence that a supplement has a general-purpose benefit.

Bicarbonate (HCO3−) is the form researchers measure in blood samples. Blood pH is a separate measurement of how acidic or alkaline the blood is.

A systematic review and meta-analysis examined acute or short-term oral sodium bicarbonate use during high-intensity intermittent exercise in team-sport athletes. Alongside its performance analysis, the team reported higher post-exercise blood bicarbonate and pH after sodium bicarbonate ingestion. The pooled differences were 2.73 mmol/L for bicarbonate (95% confidence interval 2.16 to 3.30) and 0.02 for pH (95% confidence interval 0.01 to 0.03). These are group-level results from the included exercise studies, not target values or predictions for an individual. Read the team-sport meta-analysis.

The performance findings also need context. The review found a small overall effect on high-intensity intermittent exercise performance, but did not identify clear effects for several specific outcomes, including repeated-sprint performance, mean power, intermittent endurance and work capacity. A change in blood measurements therefore should not be read as proof of a meaningful or universal performance effect. See the review’s performance and physiological results.

In short, blood bicarbonate concentration and pH help researchers describe physiological responses in the particular exercise settings they studied. They do not establish a general-purpose benefit from sodium bicarbonate, nor do they provide a basis for interpreting personal blood results. The findings should remain within the limits of the studies: team-sport athletes undertaking high-intensity intermittent exercise.

Supplement use is not the same as medical treatment

Sodium bicarbonate appears in two very different settings: sports-supplement research and medical care. Evidence from one setting should not be treated as evidence for the other. Sports studies investigate oral use in relation to exercise performance; they do not establish that a supplement can replace clinical treatment. A 2026 review of sodium bicarbonate as an ergogenic aid examines questions about supplementation and exercise, while the medical evidence discussed below concerns intravenous therapy in critically ill adults.

Participants were assigned to intravenous sodium bicarbonate titrated towards a specified pH target or to no sodium bicarbonate. This was supervised clinical treatment in a defined patient group—not self-directed use of a sports supplement or household baking soda. The meta-analysis of the BICAR-ICU and BICAR-ICU2 trials therefore cannot be used to decide whether, how or when a person should take sodium bicarbonate outside medical care.

Across 1,016 trial participants, the analysis found no statistically significant reduction in overall 90-day mortality: mortality was 58.3% in the sodium bicarbonate group and 60.6% in the control group. It did report lower use of renal replacement therapy in the sodium bicarbonate group: 34.8% compared with 50.7%. These are findings about clinical outcomes in adults with severe metabolic acidemia, under trial conditions. They are not consumer guidance, and they do not show that taking sodium bicarbonate as a supplement provides the same effects. The trial meta-analysis also describes intravenous treatment and patient subgroups, further distinguishing it from oral sports supplementation.

  • Sports supplementation research: studies oral sodium bicarbonate in the context of exercise and performance. The sports-science review addresses this research area.
  • The individual-patient meta-analysis reports the clinical outcomes.

Neither the mortality result nor the renal replacement therapy finding should be converted into advice for supplement use. Medical decisions about intravenous sodium bicarbonate belong to clinical care; sports supplementation research is a separate evidence base. The review of exercise-related supplementation and the analysis of intravenous therapy address different uses and populations.

Choosing a product and understanding the label

Start with the ingredient name, then check the format. Sodium bicarbonate is also written as NaHCO₃; looking for either name helps distinguish the ingredient from products that contain something else. The available research has examined different ways of ingesting sodium bicarbonate, including different delivery forms, but it does not establish one universally best form or protocol. A 2026 review of common questions about sodium bicarbonate and a 2026 systematic review of supplementation protocols both discuss variation in how it is delivered.

  • Confirm the ingredient: Check that the label names sodium bicarbonate or NaHCO₃. Do not assume a product is sodium bicarbonate based only on a similar-sounding name.
  • Identify the form: Note whether the product is a powder, capsule, tablet, mini-tablet, or another format. The label should specify the delivery form; do not infer it from the product name or packaging alone.
  • Read the full ingredient information: Check the ingredient list and serving information to understand what the label declares. Do not treat a serving amount as a recommendation for use.
  • Keep form separate from evidence: Studies have examined different delivery methods, including enteric-coated capsules or tablets and mini-tablets in a carbohydrate hydrogel. The systematic review reports that direct comparisons between strategies intended to reduce gastrointestinal symptoms are absent, so it cannot rank them by effectiveness. Read the review’s findings on delivery forms.
  • Do not infer a best choice: A product’s format alone does not show that it is preferable. The sources do not establish a universally best form or protocol. The review covers multiple ingestion methods, while the systematic review notes important limits in direct comparisons.

In short, use the label to verify identity and form—not to draw conclusions about performance, suitability, or a preferred protocol. The research has studied different ingestion forms, but the supplied evidence does not establish a single form as the best choice. Source review; systematic review.

Safety and practical limits

Gastrointestinal symptoms are a documented practical limitation in studies of sodium bicarbonate supplementation. A systematic review covering 101 investigations found that commonly studied acute amounts of 0.2–0.4 g per kilogram were associated with symptoms ranging from mild to severe. The review also reported that symptoms may become more likely as the amount is taken as a single dose increases. These findings describe study observations, not a personal dosing recommendation or a guarantee of what any individual will experience. The systematic review of gastrointestinal symptoms

The review grouped studies by dosing approach, including single and spread acute dosing, multi-day use, and different delivery forms. It noted that spreading intake over several hours, using enteric-coated capsules or tablets, and taking mini-tablets within a carbohydrate hydrogel have been explored as ways to reduce symptoms. However, direct comparisons between these approaches were absent, so the review could not rank their effectiveness. It also found that symptom reporting during multi-day protocols was poorly characterized. The review’s findings on protocols and reporting

The evidence has important limits. Twenty-six of the 101 studies did not use inferential statistical testing to examine differences in gastrointestinal symptoms between conditions or groups. More broadly, the review described symptom testing as inconsistent and reporting as incomplete. As a result, the available studies do not support definitive recommendations about which supplementation protocol best minimizes symptoms. The systematic review’s assessment of evidence quality

For practical decision-making, this means that a method described as potentially reducing symptoms should not be treated as proven to do so. The review identifies approaches that have been studied, but the lack of direct comparisons and gaps in symptom documentation leave uncertainty about how they compare. Its findings are specific to the supplementation protocols and studies included; they do not establish that symptoms will occur, or will not occur, for a particular person. The review of sodium bicarbonate supplementation protocols

Overall, gastrointestinal symptoms and limitations in how they have been measured are central considerations in the evidence on sodium bicarbonate supplementation. The systematic review concludes that stronger direct comparisons and more complete symptom assessment are needed before firm recommendations can be made. The systematic review’s conclusion

Safety and precautions

Gastrointestinal symptoms were reported in studies of sodium bicarbonate supplementation, with commonly studied acute amounts of 0.2–0.4 g/kg associated with symptoms ranging from mild to severe. Study amounts are not personal dosing recommendations.

Supplements with the ingredients in this article

Compare contents, dose and price

Frequently asked questions

What is sodium bicarbonate?

Sodium bicarbonate is a chemical compound with the formula NaHCO₃; baking soda is its familiar everyday name.

How has sodium bicarbonate been studied in sport?

Research has examined it in exercise settings, including high-intensity intermittent exercise, and has investigated different ingestion methods, timing and performance measures.

Do the team-sport findings show the same result for every outcome?

No. A meta-analysis found a small pooled effect for high-intensity intermittent exercise, but no clear effects for repeated-sprint performance, mean power, intermittent endurance or work capacity.

What does the evidence say about delivery forms?

Studies have examined approaches such as spread dosing, enteric-coated forms and mini-tablets in a carbohydrate hydrogel. The systematic review found no direct comparisons that would allow these approaches to be ranked for reducing gastrointestinal symptoms.

What gastrointestinal symptoms were reported in the research?

A systematic review reported that commonly studied acute amounts of 0.2–0.4 g/kg may be associated with symptoms ranging from mild to severe. These are study observations, not a prediction for an individual.

Does the research establish a universal timing or use protocol?

No. The reviews discuss timing, ingestion methods and dosing protocols, but the available evidence does not establish a universal timing recommendation or a single best protocol.

Sources

  1. Common questions and misconceptions of sodium bicarbonate as an ergogenic aid: what does the science really show? (external link)
  2. Effects of acute or short-term oral sodium bicarbonate supplementation on high-intensity intermittent exercise performance and (external link)
  3. Gastrointestinal Symptoms Associated With Sodium Bicarbonate Supplementation Protocols: A Systematic Review. (external link)
  4. Sodium bicarbonate therapy in severe metabolic acidemia: an individual patient data meta-analysis of the BICAR-ICU and BICAR-ICU2 trials. (external link)

Products related to this article

More in Supplements